DiscoverOptimum PerspectivesBiotech IPOs make a comeback in 2024
Biotech IPOs make a comeback in 2024

Biotech IPOs make a comeback in 2024

Update: 2024-05-16
Share

Description

Listen to the latest insights from Gil Bar-Nahum, Managing Director in the Global Healthcare Investment Banking Group, Jefferies International, on how to succeed in the new wave of biotech IPOs in the Optimum Perspectives podcast.

Hosted on Acast. See acast.com/privacy for more information.

Comments 
Top Podcasts
The Best New Comedy Podcast Right Now – June 2024The Best News Podcast Right Now – June 2024The Best New Business Podcast Right Now – June 2024The Best New Sports Podcast Right Now – June 2024The Best New True Crime Podcast Right Now – June 2024The Best New Joe Rogan Experience Podcast Right Now – June 20The Best New Dan Bongino Show Podcast Right Now – June 20The Best New Mark Levin Podcast – June 2024
In Channel
SpliceBio: Celebrating progress in ophthalmology research on World Sight Day

SpliceBio: Celebrating progress in ophthalmology research on World Sight Day

2024-10-1011:42

Heidelberg Pharma – turning deadly mushroom toxin into cancer medicine

Heidelberg Pharma – turning deadly mushroom toxin into cancer medicine

2024-09-1214:24

Resolution Therapeutics: pioneering macrophage therapies for liver diseases

Resolution Therapeutics: pioneering macrophage therapies for liver diseases

2024-08-0827:55

Q&A with Dr Ruth McKernan CBE: Neuroscientist, businesswoman and innovation leader

Q&A with Dr Ruth McKernan CBE: Neuroscientist, businesswoman and innovation leader

2024-07-2521:42

How AI is revolutionising drug research

How AI is revolutionising drug research

2024-05-3023:39

Curve Therapeutics – Addressing challenging drug targets

Curve Therapeutics – Addressing challenging drug targets

2024-05-2312:39

Biotech IPOs make a comeback in 2024

Biotech IPOs make a comeback in 2024

2024-05-1620:55

Anglonordic Life Science Conference strikes optimistic note for ‘24

Anglonordic Life Science Conference strikes optimistic note for ‘24

2024-05-0709:12

The challenges of recruitment for clinical trials

The challenges of recruitment for clinical trials

2024-04-0424:16

Lytix Biopharma – Innovations in Killing Cancer

Lytix Biopharma – Innovations in Killing Cancer

2024-03-0717:07

Tackling Rare Diseases in 2024

Tackling Rare Diseases in 2024

2024-02-2938:09

International Day of Women & Girls in Science: Breaking barriers and channeling your inner cavewoman

International Day of Women & Girls in Science: Breaking barriers and channeling your inner cavewoman

2024-02-0827:40

Optimum's European Life Sciences Investor Survey 2024

Optimum's European Life Sciences Investor Survey 2024

2024-01-2317:46

Vicore Pharma: Restoring lung function for IPF patients

Vicore Pharma: Restoring lung function for IPF patients

2023-12-1211:29

Optimum's Christmas charity special featuring Ariana Smiles

Optimum's Christmas charity special featuring Ariana Smiles

2023-12-0616:28

4SC: Creating a new treatment paradigm for CTCL

4SC: Creating a new treatment paradigm for CTCL

2023-11-2117:30

Episode 10: Optimum's 15th Annual Healthcare Investor Conference Special

Episode 10: Optimum's 15th Annual Healthcare Investor Conference Special

2023-11-0208:45

Ask Eva: biopharma's market trends in 2023

Ask Eva: biopharma's market trends in 2023

2023-09-0714:09

Alchemab: The UK biotech that is revolutionising drug discovery

Alchemab: The UK biotech that is revolutionising drug discovery

2023-08-2217:53

Poolbeg Pharma: Using AI to prepare for the next pandemic

Poolbeg Pharma: Using AI to prepare for the next pandemic

2023-08-0816:27

loading
Google Play
Download from Google Play
Castbox
Download from App Store
usUnited States
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Biotech IPOs make a comeback in 2024

Biotech IPOs make a comeback in 2024